Multispecific antibody formats provide a promising platform for the development of novel therapeutic concepts that could facilitate the generation of safer， more effective pharmaceuticals. However， the production and use of such antibody-based multispecifics is often made complicated by: 1) the instability of the antibody fragments of which they consist， 2) undesired inter-subunit associations， and 3) the need to include recombinant heterodimerization domains that confer distribution-impairing bulk or enhance immunogenicity. In this paper， we describe a broadly-applicable method for the stabilization of human or humanized antibody Fv fragments that entails replacing framework region IV of a V1/V3-consensus Fv framework with the corresponding germ-line sequence of a λ-type V chain. We then used this stable Fv framework to generate a novel heterodimeric multispecific antibody format that assembles by cognate V/V associations between 2 split variable domains in the core of the complex. This format， termed multispecific antibody-based therapeutics by cognate heterodimerization (MATCH)， can be applied to produce homogeneous and highly stable antibody-derived molecules that simultaneously bind 4 distinct antigens. The heterodimeric design of the MATCH format allows efficient in-format screening of binding domain combinations that result in maximal cooperative activity.